CIBA CORNING ACS PSA IMMUNOASSAY

FDA Premarket Approval P920030 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a change in the method of standardization of the calibrators for the assay

DeviceCIBA CORNING ACS PSA IMMUNOASSAY
Generic NameProstate-specific Antigen (psa) For Management Of Prostate Cancers
ApplicantBAYER HEALTHCARE, LLC
Date Received1995-09-14
Decision Date1995-12-13
PMAP920030
SupplementS001
Product CodeLTJ 
Advisory CommitteeImmunology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address BAYER HEALTHCARE, LLC 511 Benedict Ave. tarrytown, NY 10591

Supplemental Filings

Supplement NumberDateSupplement Type
P920030Original Filing
S002 1998-04-20 Panel Track
S001 1995-09-14 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.